Search alternatives:
mg decrease » _ decrease (Expand Search), we decrease (Expand Search), mean decrease (Expand Search)
wt decrease » we decrease (Expand Search), _ decrease (Expand Search), awd decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 mg » 5 mm (Expand Search)
mg decrease » _ decrease (Expand Search), we decrease (Expand Search), mean decrease (Expand Search)
wt decrease » we decrease (Expand Search), _ decrease (Expand Search), awd decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 mg » 5 mm (Expand Search)
-
461
Decrease of renal fibrosis during AT1 receptor antagonism.
Published 2013“…Values are are mean±SEM; n = 5, 9 and 13 for wild type and RenTg mice before and after irbesartan, respectively; ** P<0,01 vs WT; <sup>##</sup> P<0,01 vs RenTg. …”
-
462
-
463
-
464
Changes of miR-132-3p in peritoneal dialysis patients with different duration.
Published 2024Subjects: -
465
-
466
Regulation of TGF-<i>β</i>1 protein expression by MiR-132-3p was verified using WB.
Published 2024Subjects: -
467
-
468
-
469
-
470
-
471
-
472
-
473
-
474
-
475
-
476
-
477
-
478
Decreased synaptic density in the CA1 hippocampal area.
Published 2013“…Importantly, the total number of PSD-95/SYN contacts (synaptic density) was also decreased in the AS mouse (I). Western blot analysis of WT and AS hippocampus shows no visual differences in PSD-95 levels between WT and AS mice (J); however, there was roughly a 35% lower level of expression of SYN in AS than in WT. …”
-
479
Vectorized siRNA TMPRSS2-ERG IV-SQ impaired tumour growth and restored differentiation <i>in vivo</i>.
Published 2015“…<p><b>a.</b> SCID mice (n = 5/group) bearing VCaP tumour xenografts were injected intravenously either with NaCl 0.9%, non-vectorized siRNA TMPRSS2-ERG IV, NPs siRNA control-SQ or NPs siRNA TMPRSS2-ERG IV-SQ twice per week during 6 weeks (1.8 mg/kg/mouse cumulative dose). …”
-
480